Acasti Pharma, Inc. - (ACST) Social Stream
ACASTI PHARMA INC (ACST) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ACST.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-22 | 1 | $6 | $6 | $6 | $2.72 | 120.59% |
| 2022-06-22 | 1 | $5 | $5 | $5 | $2.72 | 83.82% |
| 2022-11-16 | 1 | $2 | $2 | $2 | $2.72 | -26.47% |
| 2022-12-15 | 2 | $2.4 | $2 | $2.2 | $2.72 | -19.12% |
| 2023-02-15 | 2 | $14.997 | $14.397 | $14.697 | $2.72 | 440.33% |
| 2023-05-09 | 3 | $2.5 | $2 | $2.3 | $2.72 | -15.44% |
| 2023-10-17 | 2 | $12 | $2.501 | $7.25 | $2.72 | 166.54% |
The Trend in the Analyst Price Target
ACST's average price target has moved up $11.49 over the prior 26 months.
ACST reports an average of 606.77% for its upside potential over the past 35 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-15 | 2 | 14.997 | 14.397 | 14.697 | 0.640 | 2196.41% |
| 2023-07-12 | 2 | 14.997 | 12.000 | 13.498 | 2.562 | 426.85% |
| 2023-10-17 | 2 | 12.000 | 2.501 | 7.250 | 2.610 | 177.78% |
| 2023-10-17 | 1 | 12.000 | 2.501 | 7.250 | 2.610 | 177.78% |
| 2023-10-17 | 1 | 14.997 | 12.000 | 13.498 | 2.610 | 417.16% |
ACST Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 36 months, ACST's average broker recommendation rating improved by 1.5.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- ACASTI PHARMA INC's number of analysts covering the stock is greater than 18.7% of all US stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ACASTI PHARMA INC's variance in analysts' estimates is lower than -16.39% of them.
- In terms of how ACASTI PHARMA INC fares relative to Healthcare stocks, note that its average analyst price target is higher than 103.51% of that group.
- To contextualize these metrics, consider that out of Healthcare stocks, ACASTI PHARMA INC's upside potential (average analyst target price relative to current price) is greater than 418.86% of them.
In the Pharmaceutical Products industry, CANF, BLRX, and GLMD are the three stocks most similar to ACASTI PHARMA INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding ACST using the data that counts. Try POWR Ratings for free.